found that USP39 activates the MAPK signaling pathway by inhibiting the phosphorylation modification of ERK1/2, which promotes tumor progression (51), suggesting that the regulation of cellular function by USP39 in melanoma may function by affecting key molecules of the signaling pathway. The gene discussed is MAPK3; the disease is neoplasm.